Serena Macrini
Arezzo, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 11, 2022
Targeted Approaches in Metastatic Castration-Resistant Prostate Cancer: Which Data?
Journal: Cancers
Published: August 10, 2022
Looking for a Simplified Diagnostic Model to Identify Potentially Lethal Cases of Prostate Cancer at Initial Diagnosis: An ImGO Pilot Study.
Journal: Cancers
Published: January 21, 2022
Nectin-4 and DNA mismatch repair proteins expression in upper urinary tract urothelial carcinoma (UTUC) as a model for tumor targeting approaches: an ImGO pilot study.
Journal: BMC cancer
Published: October 04, 2021
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation.
Journal: Cancer immunology, immunotherapy : CII
Published: July 06, 2021
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort.
Journal: Journal of translational medicine
Published: May 01, 2021
GU-CA-COVID: a clinical audit among Italian genitourinary oncologists during the first COVID-19 outbreak.
Journal: Therapeutic advances in urology
Published: March 22, 2021
Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice.
Journal: Journal for immunotherapy of cancer
Published: August 28, 2020
Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 20, 2020
Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 29, 2020
Radiotherapy in metastatic castration resistant prostate cancer patients with oligo-progression during abiraterone-enzalutamide treatment: a mono-institutional experience.
Journal: Radiation oncology (London, England)
Published: August 06, 2019
Molecular Basis of Drug Resistance and Insights for New Treatment Approaches in mCRPC.
Journal: Anticancer research
Published: August 12, 2018
Last Updated: 09/26/2026